With semaglutide, over 85% of participants achieved 5% weight loss, and about a third lost 20% or more
Gutierrez D, Weinstock A, Antharam VC, Gu H, Jasbi P, Shi X, Dirks B, Krajmalnik-Brown R, Maldonado J, Guinan J
It does not diagnose symptoms, tell you whether a side effect is dangerous, or recommend dose changes
From there, your care team stays by your side with ongoing virtual check-ins, helping you adjust, stay accountable, and celebrate your progress along the way
Los frmacos GLP-1 no han sido aprobados para el tratamiento de la adiccin y an no hay pruebas suficientes para recetarlos nicamente con ese fin